Robotic stereotactic body radiotherapy for localized prostate cancer: final analysis of the German HYPOSTAT trial

ConclusionRobotic SBRT with 35  Gy in 5 fractions was associated with a favorable short-term toxicity profile. Recruitment for the HYPOSTAT‑2 trial (ARO-2018‑4; NCT03795337), which further analyses the late toxicity of this regimen with a planned sample size of 500 patients, is ongoing.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research